AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer - TheStreet.com

AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer  TheStreet.com

Shares of AbbVie (ABBV - Get Report) were rising as the company said it would discontinue a Phase III trial of its Rova-T treatment for advanced small-cell lung ...